Author

Nirmala Pandeya

The University of QueenslandORCID 0000-0003-1462-4968Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Approach:statistical model· 3 Research Focus:GWAS / association mapping· 2 Assay:GWAS summary statistics· 2 Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:fine-mapping· 1

Frequent Co-Authors

Catherine M. OlseniD· 2 shared D. Timothy BishopiD· 2 shared David L. DuffyiD· 2 shared G J M Shanika R JayasingheiD· 2 shared Grant W. MontgomeryiD· 2 shared Jane M. PalmeriD· 2 shared Jiali HaniD· 2 shared Nicholas K. HaywardiD· 2 shared

Activity by Year

2024-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersGenetic & Genomic Medicine

Catherine M. OlsenORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Genetic & Genomic MedicinemedRxivPreprintOct 15, 2026

Melanoma germline genetics: immune, cancer driver, and Wnt signaling genes

G J M Shanika R Jayasinghe, Jianxin Shi, Rohit Thakur…·Nhan Do

This paper identifies 116 risk loci for melanoma through GWAS, links susceptibility to immunity and Wnt signaling, and develops a PRS improving risk prediction.

DOI 10.64898/2026.10.14.26365068

humanGWAS summary statistics

𝕏 PostBluesky

Genetic & Genomic MedicineNature CommunicationsPeer-reviewedMar 10, 2026

A large-scale genome-wide association meta-analysis for nevus count provides direct insights into the genetics of melanoma

G J M Shanika R Jayasinghe, Gu Zhu, Nirmala Pandeya…·Matthew H. Law

This study conducts a large-scale GWAS meta-analysis of nevus count, identifying 29 new loci and highlighting immune-related pathways relevant to melanoma risk.

3 citations

humanGWAS summary statistics

𝕏 PostBluesky

Genetic & Genomic MedicineMolecular CancerPeer-reviewedAug 5, 2024

BRCA1 secondary splice-site mutations drive exon-skipping and PARP inhibitor resistance

Ksenija Nesic, John J. Krais, Yifan Wang…·Lyndal S. Edwards

This study identifies secondary splice-site mutations in BRCA1 that drive exon skipping and PARP inhibitor resistance in ovarian and breast cancer.

36 citationstop 2%

humanbulk RNA-seq

𝕏 PostBluesky